Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_assertion description "[We sought to determine if maternal depression, anxiety, and/or treatment with selective serotonin reuptake inhibitors (SSRIs) affect placental human serotonin transporter (SLC6A4), norepinephrine transporter (SLC6A2), and 11?-hydroxysteroid dehydrogenase type 2 (11?-HSD2) gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_assertion evidence source_evidence_literature NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_assertion SIO_000772 21547899 NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_assertion wasDerivedFrom befree-20140225 NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_assertion wasGeneratedBy ECO_0000203 NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP162902.RAVw-NgSw1tfbxwI_ZX1Jto8XkCdp94Eo88YEae9i7tUE130_provenance.